Egistration: ClinicalTrials.gov, NCT00376038 Key phrases: Remogliflozin etabonate, SGLT2 inhibitor, Metformin, Pharmacokinetics
Chemexpress Egistration: ClinicalTrials.gov, NCT00376038 Key phrases: Remogliflozin etabonate, SGLT2 inhibitor, Metformin, Pharmacokinetics, Kind two diabetes mellitus Correspondence: [email protected] ^Deceased 1 GlaxoSmithKline, five Moore Drive, Investigation Triangle Park, NC 27709, USA Full…